Clinical trials recruiting for Thyroid Cancer

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
  NCT07225309 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study to Learn About the Study Medicine Called PF-07799544 as Monotherapy or in Combination in People With Advanced Solid Tumors
  NCT05538130 · Phase: Phase 1 · Ages: 16 Years and older · Sex: All (male and female) · 83 locations
• A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
  NCT05355701 · Phase: Phase 1 · Ages: 16 Years and older · Sex: All (male and female) · 40 locations
• APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
  NCT03175224 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 35 locations
• Brodalumab in the Treatment of Immune-Related Adverse Events
  NCT06673329 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
  NCT07433283 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 9 locations
• Clinico-biological Database in Patients Treated With Metabolic Radiotherapy in the Nuclear Medicine Department
  NCT04104529 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 4 locations
• DESTINY-PANTUMOUR04
  NCT07124000 · Phase: Not specified · Ages: 18 Years to 130 Years · Sex: All (male and female) · 36 locations
• Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
  NCT06239194 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• Ganoderma Spores Modulate the Gut-Brain Axis
  NCT07524777 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 80 Years · Sex: Female · 1 location
• Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
  NCT04119024 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 3 locations
• High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection Margins
  NCT06835426 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Improving Care for Rural Patients With Solid Tumors
  NCT04916990 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 28 locations
• Integrated Cancer Repository for Cancer Research
  NCT02012699 · Phase: Not specified · Ages: 19 Years to 110 Years · Sex: All (male and female) · 84 locations
• Navigation Intervention for Adolescent and Young Adult Cancer Survivors
  NCT07406087 · Phase: Not applicable (e.g. observational or device study) · Ages: 21 Years to 45 Years · Sex: All (male and female) · 1 location
• Pharmaceutical Management in Targeted Radioligand Therapy
  NCT07389512 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 3 locations
• Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
  NCT05786924 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 27 locations
• Pralsetinib DDI Study in Patients With Advanced or Metastatic Solid Tumors
  NCT07704658 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Unmet Needs of Cancer Survivors in Ausl IRCCS Reggio Emilia
  NCT06236373 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Trop2-targeted immunoPET Imaging of Solid Tumors
  NCT06851663 · Phase: Phase 2, Phase 3 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
  NCT05366881 · Phase: Not specified · Ages: 40 Years and older · Sex: All (male and female) · 17 locations

Related conditions

Trials recruiting for Thyroid Cancer often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Thyroid Cancer trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.